您的位置: 首页 > 农业专利 > 详情页

ISOLATION AND USE OF HUMAN LYMPHOID ORGAN-DERIVED SUPPRESSIVE STROMAL CELLS
专利权人:
The General Hospital Corporation d/b/a Massachusettes General Hospital;Dana-Farber Cancer Institute, Inc.
发明人:
Anne Fletcher,Shannon J. Turley,Biju Parekkadan
申请号:
US16538578
公开号:
US20200061118A1
申请日:
2019.08.12
申请国别(地区):
US
年份:
2020
代理人:
摘要:
A method for suppressing an immune response is provided. The method involves administration of isolated lymphoid tissue-derived suppressive stromal cells (LSSC) to a subject in need of such treatment in an amount effective to suppress the immune response in the subject. The invention also involves a method to isolate LSSC by digesting lymphoid tissue fragments using a combination of an enzyme mix and agitation and then collecting the LSSC. Pharmaceutical preparations comprising LSSC are also provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充